PMID: 2507110Mar 1, 1989Paper

The use of axial-pattern cutaneous and musculocutaneous flap transposition in the reconstruction of deep burns

Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns
Z Shen

Abstract

From June 1979 to July 1987, 84 acute burned patients with localized deep wounds involving tendon, nerve, vessel, bone and joint were treated by utilising 26 types of island axial-pattern cutaneous or musculocutaneous flaps. All flaps survived completely with a primary healing rate of 91.4%. All patients were divided into 'urgent' (within 48 hours), 'early' (within 2 weeks), or 'infected' groups according to the time interval between the burn injury and the surgery conducted. The primary healing rates for each groups were 100%, 94%, and 86% respectively. No significant differences exist between the axial-pattern cutaneous flap and musculo-cutaneous groups. The measures for minimizing infection including thorough debridement, groups. The measures for minimizing infection including thorough debridement, avoiding of circulatory compromises of the flaps, effectively postoperative drainage, and the use of antibiotics were discussed. Four types of newly developed axial-pattern cutaneous flaps as well as a super-long latissimus dorsi-external oblique abdominis-rectus abdominis combined musculocutaneous flaps were presented.

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.